Related Experiment Video
Updated: Jun 7, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
Hypercontractile phenotype at rest in chronic coronary syndromes predicts impaired functional reserve and increased
Quirino Ciampi1, Yi Wang2, Lauro Cortigiani3
1Division of Cardiology, Fatebenefratelli Hospital, Viale Principe di Napoli, 12, Benevento I-82100, Italy.
Insights
A hypercontractile phenotype (HP) in chronic coronary syndromes (CCS) indicates higher mortality and impaired function. Despite appearing strong, HP hearts are prognostically weaker, with reduced reserves and increased death risk.
Area of Science:
- Cardiology
- Echocardiography
- Prognostic Studies
Background:
- Transthoracic echocardiography (TTE) can identify a hypercontractile phenotype (HP) in chronic coronary syndromes (CCS).
- HP is characterized by elevated resting left ventricular (LV) elastance, calculated as systolic blood pressure divided by end-systolic volume.
- This phenotype presents a paradox of apparent strength with potential underlying weakness.
Purpose of the Study:
- To determine the prognostic significance of HP in CCS patients.
- To investigate the functional correlates of HP, including contractile and heart rate reserves.
- To assess if HP improves mortality prediction beyond traditional measures like ejection fraction (EF).
Main Methods:
- A prospective, multicenter study involving 10,677 CCS patients.
- Resting TTE was used to measure LV ejection fraction (EF), stroke volume (SV), and elastance (force).
- A subset of 5,834 patients underwent stress echocardiography to assess LV contractile reserve (LVCR) and heart rate reserve (HRR).
Main Results:
- Patients with HP (highest force quintile) had lower resting stroke volume and higher resting EF.
- Over a median 24-month follow-up, HP was associated with increased all-cause mortality (HR 1.531 vs. Q3).
- HP patients demonstrated reduced LV contractile reserve (lower ΔEF) and blunted heart rate reserve during stress testing.
Conclusions:
- HP in CCS patients identified by resting TTE signifies higher mortality risk.
- This phenotype is linked to significant functional impairments, including reduced LV contractile and chronotropic reserves.
- HP provides incremental prognostic value for mortality prediction when combined with EF, challenging the notion of a "stronger" heart being healthier.
Introduction:
Transthoracic echocardiography (TTE) identifies a hypercontractile phenotype (HP) in chronic coronary syndromes (CCS), characterized by elevated resting left ventricular (LV) elastance (force = systolic blood pressure/end-systolic volume). To evaluate the prognostic significance and functional correlates of HP.
Methods:
In a prospective multicentre study, 10 677 patients with CCS underwent resting TTE to assess LV ejection fraction (EF), stroke volume, and force by quantitative volumetric echocardiography. All patients were followed for the endpoint of all-cause mortality. In a subset of 5834 patients, stress echocardiography (exercise or dobutamine) was performed for LV contractile reserve and heart rate reserve.
Results:
Patients were stratified into Force quintiles (Q1-Q5). Patients with hypercontractile phenotype exhibited lower stroke volume at rest (Q5 = 34.8 ± 12.3 vs Q1-Q4 = 57.4 ± 19.1 mL; P < .01) and higher EF at rest (Q5 = 64.8 ± 6.9% vs Q1-Q4 = 58.1 ± 8.7%, P < .01). During a median follow-up of 24 months (interquartile range = 12-40 months), 509 deaths occurred. The exposure-adjusted death rate was lowest in Q3 (3.53-4.51 mmHg/mL; 1.03 per 100 person/years) and higher in Q1 (≤2.62 mmHg/mL, 2.88), Q2 (2.63-3.52 mmHg/mL, 1.86), Q4 (4.52-6.11 mmHg/mL, 1.56), and Q5 (HP, >6.11 mmHg/mL; 1.88; P < .0001 vs Q1 and Q3). Multivariable analysis identified HP (Q5; HR 1.531 vs Q3, 95% CI 1.116-2.099; P = .006) and EF (HR 0.963, 95% CI 0.953-0.972; P < .0001) as independent predictors of death. During exercise or dobutamine stress, HP showed reduced LV contractile reserve (ΔEF: Q5 = 4.3 ± 9.4% vs Q1-Q4 = 7.0 ± 9.3%; P < .001) and blunted heart rate reserve (Q5 = 1.77 ± 0.33 vs Q1-Q4 = 1.85 ± 0.39; P < .01). All patients with force-based LV contractile reserve >4.1 (present in 185, 3.2% of the population) survived.
Conclusion:
Patients with CCS with HP assessed by resting TTE demonstrate higher mortality and multilayered functional impairment, including reduced LV contractile and chronotropic reserves. Hypercontractile phenotype improved the prediction of mortality by EF. A 'stronger' heart is, in fact, functionally and prognostically weaker.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure